The Institute for Biotechnology and Medicine Industry said Tuesday it has developed a safer and more convenient vaccine against human respiratory syncytial virus (RSV), which causes tens of millions of infections worldwide every year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Czech envoy says Taiwan partnership in Ukraine sets global example
07/12/2025 07:40 PM - Society
United Airlines makes maiden Kaohsiung-Tokyo flight
07/12/2025 06:56 PM - Business
Carrefour, Mia C'bon suspend cooperation with JKoPay
07/12/2025 06:19 PM - Business
CPC does not rule out cooperating with U.S. shale gas suppliers
07/12/2025 05:47 PM - Society
Woman sanctioned after attacking author's wife during recall campaign
07/12/2025 05:20 PM